Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Prophylaxis for Urodynamic Examination
NCT05219877Phase 2Completed
- Sponsor
- Universitas Indonesia
- Start
- Feb 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of levofloxacin in urinary tract infection (UTI) (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Number of Participant With Urinary Tract Infection at 4 days. Started Feb 2022; status: completed.
02
Drugs
levofloxacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT05219877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05219877.